Chemistry:4'Cl-CUMYL-PINACA
From HandWiki
Short description: Chemical compound
 | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C22H26ClN3O |
| Molar mass | 383.92 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
4'Cl-CUMYL-PINACA (also known as SGT-157) is an indazole-3-carboxamide based synthetic cannabinoid compound, first disclosed in a 2014 patent.[1] It has been sold as a designer drug, first reported in 2020 alongside two similar compounds 4'F-CUMYL-5F-PICA (SGT-64) and 4'F-CUMYL-5F-PINACA (SGT-65),[2] and the metabolism of these compounds has been studied to assist with their identification in forensic casework.[3]
4'F-CUMYL-5F-PICA (SGT-64), CAS# 1631074-52-6 [1]
4'F-CUMYL-5F-PINACA (SGT-65), CAS# 1631074-53-7 [2]
See also
References
- ↑ Bowden MJ, Williamson JP, "Cannabinoid compounds", WO patent 2014167530, published 16 October 2014.
- ↑ "The e-Psychonauts' 'Spiced' World; Assessment of the Synthetic Cannabinoids' Information Available Online". Current Neuropharmacology 18 (10): 966–1051. 2020. doi:10.2174/1570159X18666200302125146. PMID 32116194.
- ↑ "Metabolism studies of 4'Cl-CUMYL-PINACA, 4'F-CUMYL-5F-PINACA and 4'F-CUMYL-5F-PICA using human hepatocytes and LC-QTOF-MS analysis". Basic & Clinical Pharmacology & Toxicology 132 (3): 263–280. December 2022. doi:10.1111/bcpt.13829. PMID 36544361. https://discovery.dundee.ac.uk/ws/files/93901959/Basic_Clin_Pharma_Tox_2022_Stalberga_Metabolism_studies_of_4_Cl_CUMYL_PINACA_4_F_CUMYL_5F_PINACA_and_4_1_.pdf.
 |  |
